Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Operating Expenses | 1,021 | 3,314 | -1,653 | 2,577 | 366 |
| Operating Income | -1,021 | -3,314 | 1,653 | -2,577 | -366 |
| Other Income | 5,690 | -3,268 | 41 | 8 | 0 |
| Pre-tax Income | 4,669 | -6,582 | 1,694 | -2,569 | -366 |
| Net Income Continuous | 4,669 | -6,582 | 1,694 | -2,569 | -366 |
| Net Income | $4,669 | $-6,582 | $1,694 | $-2,569 | $-366 |
| EPS Basic Total Ops | 0.69 | -1.17 | 0.24 | -0.54 | 0.00 |
| EPS Basic Continuous Ops | 0.68 | -1.18 | 0.25 | -0.38 | -0.15 |
| EPS Diluted Total Ops | 0.57 | -1.17 | 0.24 | -0.54 | 0.00 |
| EPS Diluted Continuous Ops | 0.56 | -1.18 | 0.25 | -0.38 | -0.15 |
| EBITDA(a) | $-1,021 | $-3,314 | $1,653 | $-2,577 | $-366 |